XML 47 R35.htm IDEA: XBRL DOCUMENT v3.25.3
Goodwill and Intangible Assets (Tables)
9 Months Ended
Sep. 30, 2025
Goodwill and Intangible Assets  
Schedule of cost, accumulated amortization and carrying amount of intangible assets

September 30, 2025

December 31, 2024

Cost

Accumulated Amortization

Carrying Amount

Cost

Accumulated Amortization

Carrying Amount

Jornay PM

$

635,000

$

(90,113)

$

544,887

$

635,000

$

(27,242)

$

607,758

Belbuca

360,000

(265,762)

94,238

360,000

(209,214)

150,786

Nucynta Products

521,170

(479,633)

41,537

521,170

(438,094)

83,076

Symproic

70,000

(25,679)

44,321

70,000

(20,218)

49,782

Total intangible assets

$

1,586,170

$

(861,187)

$

724,983

$

1,586,170

$

(694,768)

$

891,402

Schedule of amortization expense recognized in cost of product revenues

Three Months Ended September 30,

Nine Months Ended September 30,

2025

 

2024

2025

 

2024

Jornay PM

$

20,957

$

6,285

$

62,872

$

6,285

Belbuca

18,849

    

18,849

56,544

    

56,545

Nucynta Products

13,847

13,847

41,538

41,537

Symproic

1,820

1,820

5,465

5,466

Total amortization expense

$

55,473

$

40,801

$

166,419

$

109,833

Schedule of remaining amortization expense expected to be recognized

As of September 30, 2025, the remaining amortization expense expected to be recognized is as follows:

Years ended December 31,

Jornay PM

Belbuca

Nucynta Products

Symproic

Total

2025

$

20,958

$

18,845

$

13,845

$

1,824

$

55,472

2026

83,829

75,393

27,692

7,285

194,199

2027

83,829

7,285

91,114

2028

83,829

7,285

91,114

2029

83,829

7,285

91,114

Thereafter

188,613

13,357

201,970

Remaining amortization expense

$

544,887

$

94,238

$

41,537

$

44,321

$

724,983